Insulin Glargine in Type 2 Diabetic Patients

NCT00347100 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

387

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Insulin Glargine
DRUG: Glyburide
DRUG: Glyclazide
DRUG: Glimiperide
DRUG: Glipizide
DRUG: Metformin

Sponsor

Sanofi